ENOV

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Pat DorseyDorsey Asset Management $-60.7M ExitQ1 2026 $61M -- $23.11

Insider Trades

Actor	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Bodem Barbara W.Director --9.3k shares Grant / ExerciseMay 19, 2026 Disclosure amount unavailable9.3k shares -- $23.11
Kelly LiamDirector --9.3k shares Grant / ExerciseMay 19, 2026 Disclosure amount unavailable9.3k shares -- $23.11
Lalor Angela SDirector --9.3k shares Grant / ExerciseMay 19, 2026 Disclosure amount unavailable9.3k shares -- $23.11
Okala PhilipDirector --9.3k shares Grant / ExerciseMay 19, 2026 Disclosure amount unavailable9.3k shares -- $23.11
Ortiz ChristineDirector --9.3k shares Grant / ExerciseMay 19, 2026 Disclosure amount unavailable9.3k shares -- $23.11
Perfall A ClaytonDirector --9.3k shares Grant / ExerciseMay 19, 2026 Disclosure amount unavailable9.3k shares -- $23.11

News

globenewswire.comEnovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teensglobenewswire.comJun 8

fool.comront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now?fool.comMay 22

zacks.comDoes Enovis (ENOV) Have the Potential to Rally 65.45% as Wall Street Analysts Expect?zacks.comMay 13

marketbeat.comEnovis Q1 Earnings Call Highlightsmarketbeat.comMay 10

seekingalpha.comEnovis Corporation (ENOV) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 7

Trade ENOV

About Enovis Corporation

Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.

CEO: Damien McDonald
IPO Date: May 8, 2008

Market Data

Open: $23.03
High: $23.84
Low: $22.88
Volume: 563.7K
52W High: $36.82
52W Low: $20.82

Valuation

Market Cap: $1.4B
Enterprise Value: $2.7B

Financials

Free Cash Flow: $20M
Revenue: $2.2B
Net Income: $-1.2B
Cash: $36M
Debt: $1.4B

Events

EarningsAug 6

EPS est. 0.83